Jonathan Bernhard
About Jonathan Bernhard
Jonathan Bernhard serves as the Associate Director of Corporate Development at Fulcrum Therapeutics, a position he has held since 2022. He has a diverse background in healthcare consulting, research, and analytics, with previous roles at institutions such as Columbia University and Foundation Medicine.
Work at Fulcrum Therapeutics
Jonathan Bernhard has been serving as the Associate Director of Corporate Development at Fulcrum Therapeutics since 2022. In this role, he is involved in strategic initiatives that support the company's growth and development in the biotechnology sector. His experience in corporate development is essential for driving projects that align with Fulcrum's mission to advance innovative therapies.
Previous Experience in Healthcare Consulting
Before joining Fulcrum Therapeutics, Jonathan Bernhard worked at ClearView Healthcare Partners as a Consultant from 2017 to 2019. He later returned to ClearView as a Senior Consultant for a brief period in 2019. His consulting roles involved providing strategic insights and analytics to healthcare clients, contributing to informed decision-making processes in the industry.
Academic Background and Research
Jonathan Bernhard has a strong academic background, having earned a Doctor of Philosophy (PhD) from Columbia University in the City of New York from 2011 to 2016. He also completed a Master of Science (M.S.) at Purdue University from 2010 to 2011. His research experience includes a postdoctoral position at Columbia University in the Laboratory for Stem Cells and Tissue Engineering from 2016 to 2017.
Experience in Strategic Insights and Analytics
Jonathan Bernhard held multiple positions at Foundation Medicine, where he worked as Manager of Strategic Insights and Analytics from 2019 to 2021 and later as Senior Manager from 2021 to 2022. His work focused on leveraging data analytics to inform strategic decisions within the organization, contributing to the advancement of precision medicine.
Entrepreneurial Venture with EpiBone
Jonathan co-founded EpiBone, a company focused on developing innovative solutions in regenerative medicine, where he worked from 2013 to 2015. This experience reflects his commitment to advancing healthcare through entrepreneurial efforts and innovative technologies.